Peregrine Pharmaceuticals Presents Vascular Targeting Agent Technology At BIO 2002

Peregrine Pharmaceuticals Presents Data On Vasopermeation Enhancement Agent Technology At American Society of Clinical Oncology Annual Meeting

Peregrine Pharmaceuticals Announces Publication of Data Demonstrating Development of Genetically Engineered TNT Antibody Fragments Expressed in Mammalian Cells

Correcting Symbol Interpretations; Greater Than Sted Less Than

Peregrine Pharmaceuticals Announces Abstracts of Interim Results From Tumor Necrosis Therapy Treatment of Lung and Hepatic Cancers

Brain Tumor Action Week Pushes Disease Into Spotlight; Advances in Biotechnology Yield Promising Brain Tumor Treatments

Peregrine Pharmaceuticals Sponsors Education Day During Brain Tumor Action Week; Week of May 5-11 Includes Advocacy Events and Candlelight Vigil

Peregrine Pharmaceuticals Presents Advances in Vascular and Tumor Targeting Technologies at American Association for Cancer Research Annual Meeting

Avid Bioservices Announces Manufacturing Supply Agreement With Inhibitex for the Production of Therapeutic Monoclonal Antibodies

Peregrine Announces Quarterly Conference Call